生物技术与制药领域的最新动态
Cytiva Expands Bioreactor Portfolio with Addition of 500-L and 2000-L Bioreactors, Which Will be Exhibited at INTERPHEX 2025 - BioPharm International
Illumina board adds activist investor, elevates Scott Gottlieb to chair - Fierce Biotech
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors - PR Newswire
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma
Illumina DNA Prep product line | Fast, flexible library prep - Illumina
Streamlined Multiomics Data Analysis Leveraging Illumina Software on AWS - Amazon Web Services (AWS)
How Illumina designs a gene sequencer - Illumina
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate - GEN - Genetic Engineering and Biotechnology News
Trends shaping the Healthcare and Bioscience industries in 2025 - BioSpectrum Asia
Illumina aims to cut $100M in costs following China import ban - Fierce Biotech
Illumina addresses recent developments in China - PR Newswire
Illumina’s DNA sequencers hit with China import ban - MedTech Dive
Massachusetts manufacturing facility to lay off 85 employees - NBC Boston
Tech and service specialist Cytiva charts 85 layoffs at Massachusetts production site - Fierce Pharma
Mass. life sciences manufacturing facility to lay off 85 - The Business Journals
85 Mass. employees face layoffs from leading biotech company by month’s end - MassLive
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure - BioProcess International
Illumina’s high-throughput single-cell CRISPR prep makes gene editing a reality - Illumina
Illumina Innovation Roadmap - Illumina
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology - PR Newswire